These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
547 related articles for article (PubMed ID: 31103332)
21. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study. Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899 [TBL] [Abstract][Full Text] [Related]
22. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C; Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652 [TBL] [Abstract][Full Text] [Related]
23. Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study. Wang Z; Zhou X; Shi S; Liu L; Lv J; Zhang H Am J Nephrol; 2024; 55(5):529-538. PubMed ID: 39074466 [TBL] [Abstract][Full Text] [Related]
24. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases. Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674 [TBL] [Abstract][Full Text] [Related]
25. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort. Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557 [TBL] [Abstract][Full Text] [Related]
26. Association of C4d deposition with clinical outcomes in IgA nephropathy. Espinosa M; Ortega R; Sánchez M; Segarra A; Salcedo MT; González F; Camacho R; Valdivia MA; Cabrera R; López K; Pinedo F; Gutierrez E; Valera A; Leon M; Cobo MA; Rodriguez R; Ballarín J; Arce Y; García B; Muñoz MD; Praga M; Clin J Am Soc Nephrol; 2014 May; 9(5):897-904. PubMed ID: 24578331 [TBL] [Abstract][Full Text] [Related]
27. Renal arteriolar hyalinosis, not intimal thickening in large arteries, is associated with cardiovascular events in people with biopsy-proven diabetic nephropathy. Morimoto K; Matsui M; Samejima K; Kanki T; Nishimoto M; Tanabe K; Murashima M; Eriguchi M; Akai Y; Iwano M; Shiiki H; Yamada H; Kanauchi M; Dohi K; Tsuruya K; Saito Y Diabet Med; 2020 Dec; 37(12):2143-2152. PubMed ID: 32276289 [TBL] [Abstract][Full Text] [Related]
28. Clinical implication of crescentic lesions in immunoglobulin A nephropathy. Lee MJ; Kim SJ; Oh HJ; Ko KI; Koo HM; Kim CH; Doh FM; Yoo TH; Kang SW; Choi KH; Lim BJ; Jeong HJ; Han SH Nephrol Dial Transplant; 2014 Feb; 29(2):356-64. PubMed ID: 24081867 [TBL] [Abstract][Full Text] [Related]
29. Circulating soluble CD30 is associated with renal tertiary lymphoid structures and the progression of IgA nephropathy. Luo R; Qian D; Yang D; Cheng Y; Li J; Liu L; Li Y; Lei Q; Chang X; Liu Y; Xu G; Ge S Clin Chim Acta; 2024 Apr; 557():117888. PubMed ID: 38527714 [TBL] [Abstract][Full Text] [Related]
30. Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Tanaka S; Ninomiya T; Katafuchi R; Masutani K; Tsuchimoto A; Noguchi H; Hirakata H; Tsuruya K; Kitazono T Clin J Am Soc Nephrol; 2013 Dec; 8(12):2082-90. PubMed ID: 24178970 [TBL] [Abstract][Full Text] [Related]
31. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Coppo R; Troyanov S; Bellur S; Cattran D; Cook HT; Feehally J; Roberts IS; Morando L; Camilla R; Tesar V; Lunberg S; Gesualdo L; Emma F; Rollino C; Amore A; Praga M; Feriozzi S; Segoloni G; Pani A; Cancarini G; Durlik M; Moggia E; Mazzucco G; Giannakakis C; Honsova E; Sundelin BB; Di Palma AM; Ferrario F; Gutierrez E; Asunis AM; Barratt J; Tardanico R; Perkowska-Ptasinska A; Kidney Int; 2014 Oct; 86(4):828-36. PubMed ID: 24694989 [TBL] [Abstract][Full Text] [Related]
32. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy. Rhee H; Shin N; Shin MJ; Yang BY; Kim IY; Song SH; Lee DW; Lee SB; Kwak IS; Seong EY Korean J Intern Med; 2015 May; 30(3):354-61. PubMed ID: 25995666 [TBL] [Abstract][Full Text] [Related]
33. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy. Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230 [TBL] [Abstract][Full Text] [Related]
34. Serum immunoglobulin G provides early risk prediction in immunoglobulin A nephropathy. Liu D; You J; Liu Y; Tang X; Tan X; Xia M; Wu L; Chen G; He L; Zhu X; Liu H Int Immunopharmacol; 2019 Jan; 66():13-18. PubMed ID: 30415190 [TBL] [Abstract][Full Text] [Related]
35. Pregnancy and Kidney Outcomes in Patients With IgA Nephropathy: A Cohort Study. Su X; Lv J; Liu Y; Wang J; Ma X; Shi S; Liu L; Zhang H Am J Kidney Dis; 2017 Aug; 70(2):262-269. PubMed ID: 28320554 [TBL] [Abstract][Full Text] [Related]
36. Addition of eGFR and Age Improves the Prognostic Absolute Renal Risk-Model in 1,134 Norwegian Patients with IgA Nephropathy. Knoop T; Vågane AM; Vikse BE; Svarstad E; Magnúsdóttir BT; Leh S; Varberg Reisæter A; Bjørneklett R Am J Nephrol; 2015; 41(3):210-9. PubMed ID: 25872002 [TBL] [Abstract][Full Text] [Related]
37. Reversal of active glomerular lesions after immunosuppressive therapy in patients with IgA nephropathy: a repeat-biopsy based observation. Shen XH; Liang SS; Chen HM; Le WB; Jiang S; Zeng CH; Zhou ML; Zhang HT; Liu ZH J Nephrol; 2015 Aug; 28(4):441-9. PubMed ID: 25585823 [TBL] [Abstract][Full Text] [Related]
38. Relationship between blood neutrophil-lymphocyte ratio and renal tubular atrophy/interstitial fibrosis in IgA nephropathy patients. Chai L; Cai K; Wang K; Luo Q J Clin Lab Anal; 2021 Jun; 35(6):e23774. PubMed ID: 33951240 [TBL] [Abstract][Full Text] [Related]
39. Volume of Crescents Affects Prognosis of IgA Nephropathy in Patients without Obvious Chronic Renal Pathology. Lin Z; Liu L; Zhang R; Lin X; Lu F; Bao K; Wang L; Lin Q; Mai J; Cao Y; Yang H; Liu X; Zou C Am J Nephrol; 2021; 52(6):507-518. PubMed ID: 34134110 [TBL] [Abstract][Full Text] [Related]
40. Measures of Urinary Protein and Albumin in the Prediction of Progression of IgA Nephropathy. Zhao YF; Zhu L; Liu LJ; Shi SF; Lv JC; Zhang H Clin J Am Soc Nephrol; 2016 Jun; 11(6):947-955. PubMed ID: 27026518 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]